Advances in preclinical development play a crucial role in reducing cost for developing biosimilars.
Himanshu Malani
Advertisement
Himanshu Malani is a graduate student at the Indian Institute of Technology, Delhi.
Articles by Himanshu Malani
Advertisement
Latest Updated Articles
Reimagining Affordable BiosimilarsOctober 1st 2020
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
3
BioNTech's BNT113 Misses PFS Goal in Head and Neck Cancer Trial
4
Gilead Taps Vir Biotechnology's PRO-XTEN Tech for Solid Tumors
5